Resectable pancreatic adenocarcinoma Clinical Trials

Delta Trials records 15 clinical trials for Resectable pancreatic adenocarcinoma in its publicly accessible dataset. From the full dataset, 8 actively seeking eligible participants and 2 trials have reached completion. This research is conducted across 495 study locations around the world. An additional 5 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.